Safety and dose modification for patients receiving niraparib

Berek, JS; Matulonis, UA; Peen, U; Ghatage, P; Mahner, S; Redondo, A; Lesoin, A; Colombo, N; Vergote, I; Rosengarten, O; Ledermann, J; Pineda, M; Ellard, S; Sehouli, J; Gonzalez-Martin, A; Berton-Rigaud, D; Madry, R; Reinthaller, A; Hazard, S; Guo, W

Mirza, MR (reprint author), Copenhagen Univ Hosp, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.

ANNALS OF ONCOLOGY, 2018; 29 (8): 1784

Abstract

Background: Niraparib is a poly(ADP-ribose) polymerase inhibitor approved in the USA and Europe for maintenance treatment of adult patients with recur......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索